Educational reference, not medical advice

This content is for general education only. It does not constitute medical advice, diagnosis, or treatment. Traditional uses described here are not clinically validated health claims under EU Regulation EC 1924/2006 and are not authorized by EFSA. Always consult a qualified healthcare provider before starting, stopping, or combining any supplement or medication. See our Terms and Impressum.

Herb–Drug InteractionsUpdated October 20269 min read

Valerian Root for Sleep: Evidence and Documented Interactions

Valerian (Valeriana officinalis) has been used as a sleep aid for well over a thousand years. Ancient Greek and Roman physicians recommended it for restlessness, and it remained a fixture of European herbal pharmacopoeias straight through to the modern era. Today it is one of the most widely sold herbal supplements for sleep, available in capsules, tinctures, teas, and combination products.

But does it actually work? And more importantly, what are its documented interactions with other medications? This guide walks through what valerian does in the body, what the clinical research says (and doesn't say), how it stacks up against other natural sleep aids, and the drug interactions that are genuinely worth paying attention to.

Key Takeaways

  • ✓Valerian appears to work primarily by increasing GABA availability in the brain and may also influence adenosine receptors, both of which promote relaxation and sleepiness.
  • ✓Clinical evidence for valerian as a sleep aid is mixed. Some trials and meta-analyses show modest improvements in subjective sleep quality, while others find no significant benefit over placebo. The German AWMF S3 insomnia guideline does not recommend valerian or other herbal products for insomnia.
  • ✓Combining valerian with benzodiazepines, other sedatives, or alcohol can produce additive central nervous system depression, increasing the risk of excessive drowsiness and slowed breathing.
  • ✓People facing surgery are generally advised to discontinue valerian at least two weeks beforehand due to potential interactions with anesthetic agents.
  • ✓Most studies use doses between 400 and 900 mg of valerian root extract, taken 30 to 120 minutes before bed. The EMA monograph (revised 2016) advises seeing a doctor if symptoms persist beyond 2 weeks of use.
  • ✓Valerian can cause drowsiness: do not drive or operate machinery until you know how it affects you.

1. How Valerian Works: GABA Modulation and Adenosine

To understand both the promise and the risks of valerian, it helps to know what it actually does once it enters your body. Valerian root contains hundreds of compounds, but the ones that matter most for sleep fall into a few key categories: valerenic acid and its derivatives, iridoids (called valepotriates), and a range of volatile oils including isovaleric acid. These compounds work together, and their combined activity is thought to be more relevant than any single ingredient on its own.

The GABA Connection

The primary mechanism involves gamma-aminobutyric acid (GABA), your brain's main inhibitory neurotransmitter. GABA slows neural activity and promotes a calm, sleepy state. Valerian appears to increase GABA levels in the brain through several complementary pathways. Valerenic acid inhibits the enzyme responsible for breaking GABA down (GABA transaminase), which means GABA sticks around longer in the synaptic space. Additionally, valerian extracts appear to stimulate GABA release from nerve terminals and may weakly inhibit GABA reuptake, further boosting available levels.

A study published in Neuropharmacology (2007) demonstrated that valerenic acid acts as a positive allosteric modulator at GABA-A receptors, specifically at the beta-3 subunit. This is pharmacologically meaningful because it is the same general receptor complex targeted by benzodiazepines and barbiturates, though valerian binds at a different site and with much lower affinity. The overlap in receptor targets is exactly why combining valerian with prescription sedatives raises safety concerns.

Adenosine Receptor Activity

There is also emerging evidence that valerian interacts with adenosine receptors. Adenosine is one of the molecules your body uses to signal sleepiness. It accumulates during waking hours and makes you progressively drowsier (this is the same system that caffeine blocks to keep you awake). Research published in Life Sciences found that certain lignans in valerian bind to adenosine A1 receptors, which could partially explain the sedative effects that go beyond what GABA modulation alone would predict.

2. What the Sleep Research Actually Shows

Here is where things get complicated, and also where intellectual honesty matters. The clinical evidence for valerian as a sleep aid is genuinely mixed, and anyone telling you it is a slam dunk or completely useless is oversimplifying.

Positive Findings

A 2006 meta-analysis published in The American Journal of Medicine reviewed 16 eligible studies (totaling 1,093 participants) and concluded that valerian might improve subjective sleep quality without producing significant side effects. The authors were careful to note that the evidence was promising but not definitive, partly because of wide variation in study designs, preparations used, and outcome measures.

A small 2011 randomized controlled trial in Menopause reported improved sleep quality scores on the Pittsburgh Sleep Quality Index (PSQI) in postmenopausal women with insomnia taking a concentrated valerian extract, compared to placebo, over four weeks.

Negative and Mixed Findings

On the other hand, a rigorous 2007 systematic review and meta-analysis published in Sleep Medicine Reviews examined 29 trials and found that while most individual studies showed trends favoring valerian, the overall evidence was not statistically compelling when pooled. The review highlighted significant methodological problems across the literature: small sample sizes, inconsistent dosing, use of different valerian preparations (some standardized to valerenic acid, others not), and reliance on subjective outcomes.

A more recent 2020 systematic review by Shinjyo et al. in the Journal of Evidence-Based Integrative Medicine echoed these concerns, noting that valerian appears to have a small positive effect on subjective sleep quality but that objective measures like polysomnography (sleep lab recordings) have generally not confirmed significant changes in sleep onset latency, total sleep time, or sleep architecture.

What to Make of All This

The honest summary is that the evidence is mixed: some trials report modest improvements in subjective sleep quality, while objective measures largely do not. Valerian is not a replacement for cognitive behavioral therapy for insomnia (CBT-I), the first-line treatment for chronic insomnia. The German AWMF S3 insomnia guideline does not recommend valerian or other herbal products for insomnia.

3. Valerian vs. Melatonin vs. Passionflower

People considering valerian often want to know how it compares to melatonin and passionflower, the two other natural sleep aids they are most likely to encounter.

Valerian vs. Melatonin

Melatonin works through a completely different mechanism. It is a hormone your brain produces naturally in response to darkness, and it primarily regulates your circadian rhythm (your internal sleep-wake clock) rather than directly sedating you. Melatonin supplements tend to be most helpful for circadian disruptions like jet lag, shift work, or delayed sleep-wake phase disorder. Valerian, by contrast, works as a mild sedative through GABAergic (related to GABA, a calming brain chemical) activity. In practice, this means melatonin is often a better choice when the problem is timing of sleep, while valerian may be more appropriate when the issue is difficulty settling down and relaxing enough to fall asleep.

Neither substance has robust evidence for severe or chronic insomnia.

Valerian vs. Passionflower

Passionflower (Passiflora incarnata) also acts on the GABA system, primarily through flavonoids like chrysin that bind to GABA-A benzodiazepine receptors. The evidence base for passionflower is thin: a small one-week trial of passionflower tea has been published, but there are few trials overall. Some herbal products combine valerian and passionflower; dedicated studies on the combination are limited, and combining two sedating herbs adds to the drowsiness concerns below.

4. Interactions With Benzodiazepines

This is the interaction that carries the most clinical significance. Benzodiazepines (including diazepam, lorazepam, alprazolam, clonazepam, and temazepam) work by enhancing GABA activity at the GABA-A receptor. Since valerian also modulates the GABA-A receptor complex, combining the two creates a situation of additive central nervous system (CNS) depression.

The practical concern is straightforward: combining two substances that both enhance GABAergic inhibition can lead to excessive sedation, impaired coordination, slowed breathing, and in extreme cases, respiratory depression. Case reports have described adverse reactions when valerian was taken together with a benzodiazepine, although confounding factors make attribution difficult.

The Natural Medicines Comprehensive Database rates the valerian-benzodiazepine interaction as “moderate” in severity with “fair” evidence, reflecting the pharmacological plausibility and available case data. Most clinical references advise against the combination or recommend that it only be pursued under direct medical supervision with careful dose adjustment.

5. Interactions With Other Sedatives and Alcohol

The same additive sedation concern extends beyond benzodiazepines to a broader category of CNS depressants. These include:

  • Z-drugs (zolpidem, zopiclone, zaleplon), which also act on GABA-A receptors and are widely prescribed for insomnia.
  • Barbiturates, though less commonly used today, which enhance GABA activity at yet another site on the same receptor complex.
  • Antihistamines with sedating effects (diphenhydramine, doxylamine, hydroxyzine), found in many over-the-counter sleep aids. These work through a different receptor (histamine H1), but the combined CNS depression with GABA-enhancing substances like valerian can still be significant.
  • Opioid pain medications (codeine, tramadol, oxycodone), which depress respiration through mu-opioid receptors. Adding GABA-mediated sedation from valerian on top of opioid-induced respiratory depression is a combination that clinicians treat with particular caution.
  • Certain antidepressants with sedating profiles (trazodone, mirtazapine, amitriptyline) can compound drowsiness when combined with valerian.

Alcohol

Alcohol deserves special mention because it is so common and so often overlooked in supplement conversations. Alcohol enhances GABA-A receptor activity and inhibits excitatory glutamate signaling, making it a potent CNS depressant in its own right. Combining alcohol with valerian can intensify drowsiness, impair motor coordination, and slow reaction times beyond what either substance would produce alone. A 2003 study in Phytotherapy Research examined this combination in healthy volunteers and found that while valerian alone did not significantly impair psychomotor performance, the combination with alcohol produced greater impairment than alcohol alone, particularly on tasks requiring sustained attention.

6. Interactions With Anesthesia

The American Society of Anesthesiologists has included valerian on its list of herbal supplements that may interact with anesthesia. The concerns are twofold. First, valerian's GABAergic effects can potentiate the sedative properties of anesthetic agents (including propofol and sevoflurane), potentially leading to prolonged sedation or delayed recovery from anesthesia. Second, abrupt discontinuation of valerian in someone who has been taking it regularly could theoretically trigger a withdrawal-like response similar to benzodiazepine withdrawal, though this possibility is based more on pharmacological reasoning than documented cases.

The standard recommendation in the surgical literature is to discontinue valerian at least two weeks before any scheduled surgery. This gives enough time for the herb's effects to clear and for any potential rebound effects to stabilize. If an urgent surgery is needed and the patient has been taking valerian regularly, anesthesiologists typically adjust their approach accordingly, but advance planning is preferable.

7. Liver Considerations and CYP450 Enzymes

Valerian is metabolized in the liver, and there has been ongoing investigation into whether it significantly affects the cytochrome P450 enzyme system. The current evidence suggests that valerian hasmild inhibitory effects on CYP3A4, one of the most important drug-metabolizing enzymes, and possibly on CYP2D6 as well. Pharmacokinetic studies in healthy volunteers have found only modest effects on CYP3A4 and CYP2D6 probe drugs at standard doses, but they were small and short.

That said, there are a few medications where even mild CYP3A4 inhibition deserves attention. These include certain statins (atorvastatin, simvastatin), calcium channel blockers(amlodipine, felodipine), immunosuppressants (cyclosporine, tacrolimus), andsome antivirals. If you are taking any of these, mentioning your valerian use to your prescriber is worth doing, even though the interaction risk appears to be low.

Regarding liver toxicity directly, there have been rare case reports of hepatotoxicity (liver damage) potentially linked to valerian, but establishing causation has been difficult because many of these reports involved multi-ingredient products. The EMA monograph (revised 2016) advises seeing a doctor if symptoms persist beyond 2 weeks of use.

8. Dosage and Timing

One of the challenges with valerian research is that doses, preparations, and standardization vary widely across studies. That said, the most commonly studied and recommended range falls within well-defined boundaries:

  • Dose range: 400 to 900 mg of dried valerian root extract per day, taken as a single dose before bedtime. Some studies have used divided doses (e.g., 300 mg twice daily plus 300 mg at bedtime), but the single nighttime dose is more common in the sleep-focused literature.
  • Standardization: Products standardized to 0.8% valerenic acid provide a useful benchmark for comparing products and aligning with study protocols. Not all commercial products meet this standard, which is one reason results can vary from person to person.
  • Timing: Most studies instruct participants to take valerian 30 to 120 minutes before intended bedtime. The wide window reflects individual variation in absorption and response. Some people notice the relaxing effects within 30 minutes, while others find that taking it one to two hours before bed works better.
  • Form: Capsules and tablets of standardized extract are the most studied forms. Valerian tea is also traditional, though the dose per cup is harder to standardize and typically delivers less valerenic acid than capsule forms. Tinctures (alcohol-based extracts) are another option, though the alcohol content is worth noting for people avoiding alcohol.

Higher doses do not appear to produce proportionally better sleep outcomes. A 2002 dose-response study in Pharmacopsychiatry found no meaningful difference in sleep quality between 450 mg and 900 mg of valerian extract, suggesting that more is not necessarily better and that starting at the lower end of the range is a reasonable approach.

9. How Long It Takes to Work

Unlike a benzodiazepine or a Z-drug, which produces noticeable effects on the first night of use, valerian has been proposed to act gradually. Some studies have reported that improvements in subjective sleep quality emerged only after 2 to 4 weeks of daily use; others found no benefit.

A 28-day trial published in Pharmacopsychiatry (2000) found that improvements in sleep quality scores became statistically significant only after day 14.

The EMA monograph (revised 2016) advises seeing a doctor if symptoms persist beyond 2 weeks of use. Insomnia that persists deserves assessment rather than a longer trial of a supplement.

10. Who Should Avoid Valerian

While few adverse effects have been reported in adults at recommended doses for limited periods, certain groups face elevated risk or have insufficient safety data:

  • People taking benzodiazepines, Z-drugs, or other prescription sedatives. The risk of additive CNS depression is well-established pharmacologically and supported by clinical observation. This combination is generally not recommended without explicit guidance from a prescriber.
  • People who consume alcohol regularly or heavily. The additive sedation and psychomotor impairment documented in combination studies makes this a concern, particularly for anyone who drives or operates machinery.
  • People with scheduled surgery within the next two weeks. As discussed above, valerian's potential to interact with anesthetic agents and the possibility of withdrawal-like effects make pre-surgical discontinuation a standard recommendation.
  • Pregnant and breastfeeding individuals. There is insufficient safety data to recommend valerian during pregnancy or lactation. Some valepotriates have shown mutagenic potential in laboratory assays, and while these compounds are largely degraded during processing, the precautionary principle applies.
  • Anyone who needs to drive or operate machinery. Valerian can cause drowsiness and may impair the ability to drive or use machines.
  • Children under 12. The European Medicines Agency and most herbal medicine references do not recommend valerian for children under 12 due to insufficient pediatric safety data.
  • People with significant liver disease. Given valerian's hepatic metabolism and the rare reports of liver-related adverse effects, individuals with pre-existing liver conditions are generally advised to avoid it or use it only with medical oversight.
  • People taking medications with narrow therapeutic windows that are CYP3A4 substrates. While valerian's CYP3A4 inhibition appears mild, medications like cyclosporine, tacrolimus, and certain statins leave little room for altered metabolism, so the combination warrants a conversation with a prescriber.

It is also worth noting that some people experience a paradoxical reaction to valerian, feeling more restless or anxious rather than calmer. This appears to be uncommon but is documented in the literature. If valerian consistently makes you feel wired rather than relaxed, it is not the right fit.

Sources & Further Reading

  • Bent S, et al. "Valerian for sleep: a systematic review and meta-analysis." Am J Med. 2006;119(12):1005-1012.
  • Fernandez-San-Martin MI, et al. "Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials." Sleep Med. 2010;11(6):505-511.
  • Khom S, et al. "Valerenic acid potentiates and inhibits GABA-A receptors." Neuropharmacology. 2007;53(1):178-187.
  • Diaper A, Hindmarch I. "A double-blind, placebo-controlled investigation of the effects of two doses of valerian on sleep, cognitive and psychomotor function." Pharmacopsychiatry. 2002;35(6):227-233.
  • Donath F, et al. "Critical evaluation of the effect of valerian extract on sleep structure and sleep quality." Pharmacopsychiatry. 2000;33(2):47-53.
  • National Center for Complementary and Integrative Health (NCCIH). "Valerian." nccih.nih.gov.
  • European Medicines Agency (EMA), HMPC. "European Union herbal monograph on Valeriana officinalis L., radix." Revised 2016.
  • Taibi DM, et al. "A systematic review of valerian as a sleep aid: safe but not effective." Sleep Med Rev. 2007;11(3):209-230. PMID 17517355.
  • Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). "S3-Leitlinie Insomnie bei Erwachsenen" (AWMF 063-003). register.awmf.org/de/leitlinien/detail/063-003.
  • Natural Medicines Comprehensive Database. "Valerian Monograph." Therapeutic Research Center.
  • Shinjyo N, Waddell G, Green J. "Valerian root in treating sleep problems and associated disorders: a systematic review and meta-analysis." J Evid Based Integr Med. 2020;25:2515690X20967323. PMID 33086877.
  • Ngan A, Conduit R. "A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata herbal tea on subjective sleep quality." Phytother Res. 2011;25(8):1153-1159.

This article synthesizes findings from peer-reviewed research, pharmacological databases, and clinical monographs. It is intended for educational purposes and does not constitute medical advice.

Check your specific combination

Enter your medications and any supplements you're considering into our free Interaction Reference.

Open Interaction Reference

Educational Disclaimer

The content on this page is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Traditional uses described here are not clinically validated health claims under EU Regulation EC 1924/2006 and are not authorized by EFSA. The information presented here does not replace a consultation with a qualified healthcare provider. Never start, stop, or change any medication or supplement regimen based solely on information found on this website. If you are experiencing a medical emergency, contact your local emergency services immediately. Individual results may vary, and what works for one person may not be appropriate for another.